You're reading the free version. Trader adds the live tape and alerts.
Start tracking
PVCT Award Disclosure
Lacey John Iii · SEC Form 4 · Filed Jun 30, 2026
Award
Calculated transaction value
$0
Lacey John Iii Director
PVCT
Transaction date
Jun 30, 2026
Public filing date
Jun 30, 2026
Filing lag
Filed same day
PVCT daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Series D-1 Convertible Preferred Stock on Common Stock
- Quantity / price
- 48,917 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001493152-26-031403
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Provectus Biopharmaceuticals, Inc. PVCT Current | Award | Jun 30, 2026 | $0 |